Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/23759
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | DOOLEY, Dearbhaile | - |
dc.contributor.author | LEMMENS, Evi | - |
dc.contributor.author | VANGANSEWINKEL, Tim | - |
dc.contributor.author | Le Blon, Debbie | - |
dc.contributor.author | Hoornaert, Chloe | - |
dc.contributor.author | Ponsaerts, Peter | - |
dc.contributor.author | HENDRIX, Sven | - |
dc.date.accessioned | 2017-05-18T13:24:11Z | - |
dc.date.available | 2017-05-18T13:24:11Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | STEM CELL REPORTS, 7(6), p. 1099-1115 | - |
dc.identifier.issn | 2213-6711 | - |
dc.identifier.uri | http://hdl.handle.net/1942/23759 | - |
dc.description.abstract | The therapeutic effects of mesenchymal stem cell (MSC) transplantation following spinal cord injury (SCI) to date have been limited. Therefore, we aimed to enhance the immunomodulatory properties of MSCs via continuous secretion of the anti-inflammatory cytokine interleukin-13 (IL-13). By using MSCs as carriers of IL-13 (MSC/IL-13), we investigated their therapeutic potential, compared with non-engineered MSCs, in a mouse model of SCI. We show that transplanted MSC/IL-13 significantly improve functional recovery following SCI, and also decrease lesion size and demyelinated area by more than 40%. Further histological analyses in CX(3)CR1(EGFP/+) CCR2(RFP/+) transgenic mice indicated that MSC/IL-13 significantly decrease the number of resident microglia and increase the number of alternatively activated macrophages. In addition, the number of macrophage-axon contacts in MSC/IL-13-treated mice was decreased by 50%, suggesting a reduction in axonal dieback. Our data provide evidence that transplantation of MSC/IL-13 leads to improved functional and histopathological recovery in a mouse model of SCI. | - |
dc.description.sponsorship | The authors would like to acknowledge Dr. Leen Timmermans for her excellent technical assistance. This manuscript was supported in part by grants from Fonds Wetenschappelijk Onderzoek - Vlaanderen awarded to S.H. (G.0834.11N, G.0389.12), E.L. (G6058.13N), and P.P. (G.0130.11, G.0131.11, G.0834.11N). D.D. is a PhD student at the Transnational University Limburg and the University of Antwerp. C.H. holds a PhD studentship from the FWO Vlaanderen. At the time of this study, T.V. and D.l.B. held PhD studentships from the Flemish Institute for Science and Technology (IWT Vlaanderen). | - |
dc.language.iso | en | - |
dc.publisher | CELL PRESS | - |
dc.rights | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | - |
dc.subject.other | mesenchymal stem cells; interleukin-13; spinal cord injury; cell transplantation; microglia; macrophages | - |
dc.title | Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord Injury | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 1115 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 1099 | - |
dc.identifier.volume | 7 | - |
local.format.pages | 17 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Dooley, Dearbhaile; Lemmens, Evi; Vangansewinkel, Tim; Hendrix, Sven] Hasselt Univ, Biomed Res Inst, Dept Morphol, Martelarenlaan 42, B-3500 Hasselt, Belgium. [Dooley, Dearbhaile; Le Blon, Debbie; Hoornaert, Chloe; Ponsaerts, Peter] Univ Antwerp, Vaccine & Infect Dis Inst Vaxinfectio, Lab Expt Hematol, B-2610 Antwerp, Belgium. | - |
local.publisher.place | CAMBRIDGE | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
local.class | dsPublValOverrule/author_version_not_expected | - |
dc.identifier.doi | 10.1016/j.stemcr.2016.11.005 | - |
dc.identifier.isi | 000393188500008 | - |
item.validation | ecoom 2018 | - |
item.contributor | DOOLEY, Dearbhaile | - |
item.contributor | LEMMENS, Evi | - |
item.contributor | VANGANSEWINKEL, Tim | - |
item.contributor | Le Blon, Debbie | - |
item.contributor | Hoornaert, Chloe | - |
item.contributor | Ponsaerts, Peter | - |
item.contributor | HENDRIX, Sven | - |
item.accessRights | Open Access | - |
item.fullcitation | DOOLEY, Dearbhaile; LEMMENS, Evi; VANGANSEWINKEL, Tim; Le Blon, Debbie; Hoornaert, Chloe; Ponsaerts, Peter & HENDRIX, Sven (2016) Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord Injury. In: STEM CELL REPORTS, 7(6), p. 1099-1115. | - |
item.fulltext | With Fulltext | - |
crisitem.journal.issn | 2213-6711 | - |
crisitem.journal.eissn | 2213-6711 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
dooley 1.pdf | Published version | 7.11 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
27
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
61
checked on May 2, 2024
Page view(s)
88
checked on Sep 7, 2022
Download(s)
106
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.